Sorafenib modulates the radio sensitivity of hepatocellular carcinoma cells <it>in vitro</it> in a schedule-dependent manner
<p>Abstract</p> <p>Background</p> <p>Hepatocellular carcinoma (HCC) has a high incidence and mortality. Radiotherapy and sorafenib have proven effective for HCC. Here, we investigated whether sorafenib modulated the response of HCC cells to irradiation <it>in vitr...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-10-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2407/12/485 |